Citigroup’s Eledon Pharmaceuticals ELDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $53.5K | Sell |
19,738
-1,273
| -6% | -$3.45K | ﹤0.01% | 3992 |
|
|
2025
Q1 | $71.2K | Sell |
21,011
-45,889
| -69% | -$156K | ﹤0.01% | 4002 |
|
|
2024
Q4 | $276K | Buy |
+66,900
| New | +$276K | ﹤0.01% | 3378 |
|
|
2021
Q2 | – | Sell |
-2,166
| Closed | -$23K | – | 5472 |
|
|
2021
Q1 | $23K | Buy |
+2,166
| New | +$23K | ﹤0.01% | 4500 |
|
|
2017
Q2 | – | Sell |
-1
| Closed | – | – | 4889 |
|
|
2017
Q1 | $0 | Sell |
1
-61
| -98% | – | ﹤0.01% | 4821 |
|
|
2016
Q4 | $10K | Buy |
62
+29
| +88% | +$4.68K | ﹤0.01% | 4525 |
|
|
2016
Q3 | $8K | Hold |
33
| – | – | ﹤0.01% | 4514 |
|
|
2016
Q2 | $30K | Sell |
33
-68
| -67% | -$61.8K | ﹤0.01% | 3961 |
|
|
2016
Q1 | $92K | Buy |
101
+23
| +29% | +$21K | ﹤0.01% | 3984 |
|
|
2015
Q4 | $111K | Buy |
78
+36
| +86% | +$51.2K | ﹤0.01% | 3517 |
|
|
2015
Q3 | $71K | Buy |
42
+11
| +35% | +$18.6K | ﹤0.01% | 3363 |
|
|
2015
Q2 | $67K | Sell |
31
-5
| -14% | -$10.8K | ﹤0.01% | 3532 |
|
|
2015
Q1 | $67K | Buy |
36
+30
| +500% | +$55.8K | ﹤0.01% | 3670 |
|
|
2014
Q4 | $15K | Buy |
6
+2
| +50% | +$5K | ﹤0.01% | 4711 |
|
|
2014
Q3 | $11K | Buy |
+4
| New | +$11K | ﹤0.01% | 4569 |
|